Clean Science & Technology Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹245Cr
- +2.9% YoY
- +0.8% QoQ
- Net profit
- ₹55Cr
- −6.8% YoY
- −21.4% QoQ
- Margin
- 36%
- −2 pp YoY
- −5 pp QoQ
Guidance rank: #55 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and plans to increase capacity utilization and revenues over the next two quarters. HALS segment showing strong growth with 25% QoQ volume increase; expected to continue quarter-on-quarter growth, improving capacity utilization and revenues in next two quarters.
From Clean Science & Technology Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and plans to increase capacity utilization and revenues over the next two quarters.
- Performance Chemicals Unit 1 capacity started with ~1,000 tons per annum, aiming for clearer customer demand next quarter before scaling further.
- Performance Chemicals Unit 2 facility scheduled to start water trials in April 2026 and commercial production by June 2026, with a 3-year ramp-up expected.
- The company targets INR 300 crore revenue from 10,000 tons capacity in Performance Chemicals by FY28.
- Domestic market (mainly HALS) grew 13% in H1 FY26; still room to expand customer base with 70-75% capacity utilization for food-grade antioxidants.
- Growth in new products and markets (US, Europe, Vietnam, Middle East, South Africa) expected as product acceptance improves.
2 more points from Clean Science & Technology Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Clean Science & Technology Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Clean Science invested approximately INR 150 crores in the subsidiary (CFCL) during H1 FY26.
- Performance Chemical 1 facility is undergoing chemical trials with commercialization expected within 3-4 weeks.
- Performance Chemical 2 facility water trials to start in April with commercial production anticipated by June; ramp-up expected over approximately 3 years.
- Capacity expansion of some food-grade antioxidants has been successfully completed.
- A new product (hydroxychloroquine-related) with an installed capacity of about 10,000 tons aims to generate approximately INR 300 crores revenue by FY28.
2 more points from Clean Science & Technology Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Clean Science & Technology Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company has started commercial samples for Performance Chemical One with less than 1,000 tons per annum of existing capacity utilized through refurbishment.
- Full installed capacity for Performance Chemical One is about 10,000 tons, with revenue potential of around INR 300 crores by FY 2028.
- Commercialization of barbituric acid successfully completed by repurposing existing facilities.
- Capacity expansions have been done for some food-grade antioxidants.
- Sales for Performance Chemical One and barbituric acid expected to gather momentum with increasing approvals and validations over coming quarters.
- Sales volumes for HALS products growing sequentially at 25% volume and 34% value growth.
2 more points from Clean Science & Technology Ltd's call on order book
Create a free account to keep reading this call
Clean Science & Technology Ltd — Quarterly revenue & net profit
Clean Science & Technology Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 245 | 238 | +2.9% | 243 | +0.8% |
| Operating profit (EBITDA) | 87 | 90 | -3.3% | 100 | -13% |
| Operating margin | 36% | 38% | -2 pp | 41% | -5 pp |
| Profit before tax | 75 | 83 | -9.6% | 95 | -21.1% |
| Net profit (PAT) | 55 | 59 | -6.8% | 70 | -21.4% |
| EPS (₹) | 5.22 | 5.53 | -5.6% | 6.59 | -20.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹299 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Clean Science's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Dynemic Products (Q2 FY26)
Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a
- Platinum Industr (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- IVP (Q2 FY26)
Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Clean Science & Technology Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Clean Science & Technology Ltd Q2 FY26 results?
HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and plans to increase capacity utilization and revenues over the next two quarters. HALS segment showing strong growth with 25% QoQ volume increase; expected to continue quarter-on-quarter growth, improving capacity utilization and revenues in next two quarters.
What is Clean Science & Technology Ltd share price analysis?
Clean Science & Technology Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹8,173 Cr. Investors should review the full earnings analysis for detailed insights.
Is Clean Science & Technology Ltd planning capital expenditure?
Clean Science invested approximately INR 150 crores in the subsidiary (CFCL) during H1 FY26.
Keep Clean Science & Technology Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
